Vilner BJ[au] - Search Results

Year	Number of Results
1993	2
1994	1
1995	6
1996	1
1997	2
1998	1
1999	4
2000	1
2022	0

1

Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity.

Bowen WD, Vilner BJ, Williams W, Bertha CM, Kuehne ME, Jacobson AE. Bowen WD, et al. Among authors: vilner bj. Eur J Pharmacol. 1995 Jun 6;279(1):R1-3. doi: 10.1016/0014-2999(95)00247-i. Eur J Pharmacol. 1995. PMID: 7556375

2

Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture.

Vilner BJ, Bowen WD. Vilner BJ, et al. Eur J Pharmacol. 1993 Jan 15;244(2):199-201. doi: 10.1016/0922-4106(93)90029-9. Eur J Pharmacol. 1993. PMID: 8094338

3

Substituted halogenated arylsulfonamides: a new class of sigma receptor binding tumor imaging agents.

John CS, Lim BB, Vilner BJ, Geyer BC, Bowen WD. John CS, et al. Among authors: vilner bj. J Med Chem. 1998 Jul 2;41(14):2445-50. doi: 10.1021/jm9800447. J Med Chem. 1998. PMID: 9651150

4

Isothiocyanate derivatives of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole): irreversible ligands for the dopamine transporter.

Husbands SM, Izenwasser S, Loeloff RJ, Katz JL, Bowen WD, Vilner BJ, Newman AH. Husbands SM, et al. Among authors: vilner bj. J Med Chem. 1997 Dec 19;40(26):4340-46. doi: 10.1021/jm9705519. J Med Chem. 1997. PMID: 9435903

5

Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability.

Vilner BJ, de Costa BR, Bowen WD. Vilner BJ, et al. J Neurosci. 1995 Jan;15(1 Pt 1):117-34. doi: 10.1523/JNEUROSCI.15-01-00117.1995. J Neurosci. 1995. PMID: 7823122 Free PMC article.

6

Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.

John CS, Vilner BJ, Geyer BC, Moody T, Bowen WD. John CS, et al. Among authors: vilner bj. Cancer Res. 1999 Sep 15;59(18):4578-83. Cancer Res. 1999. PMID: 10493511

7

Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.

John CS, Bowen WD, Fisher SJ, Lim BB, Geyer BC, Vilner BJ, Wahl RL. John CS, et al. Among authors: vilner bj. Nucl Med Biol. 1999 May;26(4):377-82. doi: 10.1016/s0969-8051(98)00104-8. Nucl Med Biol. 1999. PMID: 10382840

8

99mTc-labeled sigma-receptor-binding complex: synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells.

John CS, Lim BB, Geyer BC, Vilner BJ, Bowen WD. John CS, et al. Among authors: vilner bj. Bioconjug Chem. 1997 May-Jun;8(3):304-9. doi: 10.1021/bc9700087. Bioconjug Chem. 1997. PMID: 9177835

9

A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)4-iodobenzamide.

John CS, Bowen WD, Saga T, Kinuya S, Vilner BJ, Baumgold J, Paik CH, Reba RC, Neumann RD, Varma VM, et al. John CS, et al. Among authors: vilner bj. J Nucl Med. 1993 Dec;34(12):2169-75. J Nucl Med. 1993. PMID: 8254405 Free article.

10

Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells.

Vilner BJ, Bowen WD. Vilner BJ, et al. J Pharmacol Exp Ther. 2000 Mar;292(3):900-11. J Pharmacol Exp Ther. 2000. PMID: 10688603

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results